Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: diclofenac

Rheumatology Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  March 1, 2014

Information on new approvals and medication safety that rheumatologists need to know

Filed under:Axial SpondyloarthritisConditionsDrug UpdatesOsteoarthritis and Bone DisordersPsoriatic ArthritisRheumatoid Arthritis Tagged with:Ankylosing Spondylitisanti-inflammatoryApprovalsdrugFDAMethotrexateOsteoarthritisPipelinePsoriatic ArthritisRheumatoid arthritisrheumatologistrheumatologySafety

ACR/ARHP Annual Meeting 2012: New Research Into Stem Cell Therapy and Drugs May Lead to Breakthrough Treatments for Osteoarthritis

Susan Bernstein  |  February 1, 2013

Novel strategies for treating osteoarthritis aim to relieve pain, rebuild or replenish deteriorated cartilage and bone, or to replace the joint through surgery

Filed under:ConditionsMeeting ReportsOsteoarthritis and Bone DisordersResearch Rheum Tagged with:OsteoarthritisResearchStem CellsTreatment

Minerals, Mud, Martinis, and Methylprednisone

Simon M. Helfgott, MD  |  June 10, 2012

How the practice of rheumatology differs in America and Europe.

Filed under:Axial SpondyloarthritisConditionsDrug UpdatesEULAR/OtherMeeting ReportsOpinionOsteoarthritis and Bone DisordersPain SyndromesRheumatoid ArthritisRheuminationsSpeak Out Rheum Tagged with:AC&RAmerican College of Rheumatology (ACR)Ankylosing Spondylitisanti-inflammatorydrugEULARFibromyalgiaglucocorticoidHelfgottMethotrexateOsteoarthritisradiographRheumatoid arthritisSteroids

Letters

Staff  |  September 1, 2011

Feedback from our readers

Filed under:Drug Updates Tagged with:AutoimmuneDrugsMethotrexateRheumatoid arthritis

High Cost, No Benefit

Aryeh M. Abeles, MD  |  July 12, 2011

Why are so many brand-name drugs approved after generic versions become available?

Filed under:Drug Updates Tagged with:ApprovalsDrugsFDASafety

Are NSAIDS Even Less Safe Than We Thought?

Mary Desmond Pinkowish  |  March 18, 2011

Recent meta-analysis points to MI risks, but many questions remain

Filed under:AnalgesicsDrug Updates Tagged with:Cardiovascular diseaseDrugsNSAIDPainrheumatologiststroke

Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  September 1, 2010

Information on New Approvals and Medication Safety

Filed under:Drug Updates Tagged with:ApprovalsDrugsPipline

Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  March 1, 2010

Information on New Approvals and Medication Safety

Filed under:Drug Updates Tagged with:ApprovalsPipelineSLESystemic lupus erythematosus

Drug Updates: Information on New Approvals and Medication Safety

Michele B. Kaufman, PharmD, BCGP  |  January 1, 2010

Information on New Approvals and Medication Safety

Filed under:ConditionsDrug UpdatesOsteoarthritis and Bone Disorders Tagged with:ApprovalsLansoprazoleOsteoporosisPipeline

Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  September 1, 2009

Information on New Approvals and Medication Safety

Filed under:Drug Updates Tagged with:acetaminophenApprovalsFDALabeling ChangesPipeline

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences